AI Summary
5 min readMeta agreed to an $18 billion settlement with nearly all U.S. states over claims that Facebook and Instagram harmed teenagers, ending a federal trial in Oakland that was just getting started. The deal will impose default time limits, a nighttime shutdown, and a school mode that blocks notifications during class hours for users under 18. In other developments, Nvidia reported another blowout quarter, the FDA approved a breakthrough pancreatic cancer drug, and the FBI took down a sprawling Chinese hacking network whose targets included NASA and the Federal Reserve.
Meta’s $18 Billion Teen Safety Settlement
Meta settled the massive multi-state lawsuit on the first day of trial, avoiding what could have been more than $200 billion in liability. The company had already lost two major trials this year, and this third case was the biggest yet. The settlement applies to users under 18 on Facebook and Instagram. Settings that previously existed on an opt-in basis will now be the default: push notifications will be disabled, like counts will be hidden, and teens will get a pop-up every 15 minutes they are using the app, with warnings at one hour, 90 minutes, and a hard daily limit of two hours. There are no changes for adult users.
Continue reading the full summary in the app — free to try.
Read Full Summary →Free • No credit card required
Never miss an episode of WSJ What’s News
Get every new episode summarized in your inbox — free, ~5 minutes to read.
No spam. Unsubscribe anytime.
What you'll learn
- 1 (00:18) **Meta Reaches $18 Billion Settlement on Teen Harm Claims** - The episode opens with Meta agreeing to a landmark settlement with nearly all U.S. states over claims that Facebook and Instagram harmed teenagers, ending a massive federal trial before it could begin.
- 2 (03:38) **Nvidia Reports Blowout Quarter, Shares Dip in After-Hours** - Nvidia reported sales of over $96 billion, beating Wall Street expectations, but investors sent shares down in after-hours trading.
- 3 (04:03) **FBI Shuts Down Chinese Hacking Operation Targeting U.S. Agencies** - U.S. officials say they have dismantled a large-scale hacking operation linked to China that targeted NASA, the Federal Reserve, the Department of Energy, the Senate, power companies, and hospitals.
- 4 (04:43) **FDA Approves Breakthrough Pancreatic Cancer Drug Razon Q** - The FDA approved a new drug from Revolution Medicines that targets a mutation driving a third of all human cancers, with study results showing patients lived nearly twice as long as those on chemotherapy alone.
- 5 (07:04) **Markets Close Slightly Lower; Fed's Preferred Inflation Metric Holds Steady** - Stocks ended the day down slightly, with the Dow losing 0.2%, as the Fed's preferred inflation gauge remained at 3.7% for July.
- 6 (07:31) **Trump Administration Imposes New Financial Vetting for Immigrant Visas** - The administration is training officers on new guidance for vetting applicants' finances, continuing efforts to limit legal immigration by people of limited financial means.
- 7 (08:45) **Flash Floods Devastate Nepal-Tibet Border, Killing at Least 100** - Flash floods tore through towns along a popular pilgrimage route, killing at least 100 people, with hundreds more missing, including over 130 travelers from India and nearly 50 from the U.S.
+ Full timestamped outline available in the app
Show Notes
P.M. Edition for Aug. 26. Tech reporter Meghan Bobrowsky tells us why the Meta settlement could change how teenagers use some of the world’s most popular apps.
Plus, the FDA approves a milestone therapy for pancreatic cancer. WSJ reporter Xavier Martinez discusses how the nearly $40,000-a-month drug from Revolution Medicines could change patient outcomes of one the deadliest cancers. And the FBI shuts down a sprawling hacking network linked to China that targeted NASA, the Federal Reserve and critical infrastructure. Sabrina Siddiqui hosts.
Sign up for the WSJ's free What's News newsletter.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
More from this podcast
WSJ What’s News →